News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
356,473 Results
Type
Article (15089)
Company Profile (76)
Press Release (341306)
Multimedia
Podcasts (20)
Webinars (5)
Section
Business (104317)
Career Advice (476)
Deals (21549)
Drug Delivery (24)
Drug Development (44507)
Employer Resources (66)
FDA (8452)
Job Trends (9443)
News (180405)
Policy (18870)
Tag
Academia (1746)
Academic (1)
Accelerated approval (12)
Adcomms (7)
Allergies (61)
Alliances (22189)
ALS (70)
Alzheimer's disease (773)
Antibody-drug conjugate (ADC) (102)
Approvals (8631)
Artificial intelligence (137)
Autoimmune disease (59)
Automation (11)
Bankruptcy (194)
Best Places to Work (8626)
BIOSECURE Act (4)
Biosimilars (67)
Biotechnology (50)
Bladder cancer (100)
Brain cancer (29)
Breast cancer (299)
Cancer (2350)
Cardiovascular disease (178)
Career advice (416)
Career pathing (5)
CAR-T (170)
CDC (40)
Cell therapy (360)
Cervical cancer (17)
Clinical research (37658)
Collaboration (571)
Compensation (306)
Complete response letters (19)
COVID-19 (2928)
CRISPR (29)
C-suite (266)
Cystic fibrosis (70)
Data (3420)
Decentralized trials (2)
Denatured (5)
Depression (63)
Diabetes (218)
Diagnostics (4003)
Digital health (19)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (73)
Drug pricing (32)
Drug shortages (8)
Duchenne muscular dystrophy (99)
Earnings (51269)
Editorial (22)
Employer branding (5)
Employer resources (58)
Events (54564)
Executive appointments (393)
FDA (10029)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (13)
Funding (471)
Gene editing (74)
Generative AI (7)
Gene therapy (214)
GLP-1 (413)
Government (3529)
Grass and pollen (1)
Guidances (349)
Healthcare (12715)
HIV (32)
Huntington's disease (11)
IgA nephropathy (53)
Immunology and inflammation (104)
Immuno-oncology (13)
Indications (43)
Infectious disease (3083)
Inflammatory bowel disease (104)
Inflation Reduction Act (4)
Influenza (75)
Intellectual property (135)
Interviews (84)
IPO (11697)
IRA (7)
Job creations (1156)
Job search strategy (358)
Kidney cancer (9)
Labor market (26)
Layoffs (196)
Leadership (9)
Legal (3829)
Liver cancer (52)
Longevity (6)
Lung cancer (327)
Lymphoma (244)
Machine learning (14)
Management (28)
Manufacturing (259)
MASH (98)
Medical device (7494)
Medtech (7516)
Mergers & acquisitions (10488)
Metabolic disorders (548)
Multiple sclerosis (71)
NASH (6)
Neurodegenerative disease (108)
Neuropsychiatric disorders (24)
Neuroscience (1242)
NextGen: Class of 2025 (4686)
Non-profit (3266)
Now hiring (13)
Obesity (230)
Opinion (84)
Ovarian cancer (97)
Pain (82)
Pancreatic cancer (110)
Parkinson's disease (114)
Partnered (10)
Patents (253)
Patient recruitment (158)
Peanut (19)
People (28755)
Pharmaceutical (16)
Pharmacy benefit managers (9)
Phase I (11246)
Phase II (16418)
Phase III (13584)
Pipeline (2623)
Policy (108)
Postmarket research (1240)
Preclinical (4376)
Press Release (25)
Prostate cancer (123)
Psychedelics (14)
Radiopharmaceuticals (98)
Rare diseases (351)
Real estate (2439)
Recruiting (29)
Regulatory (13710)
Reports (18)
Research institute (1577)
Resumes & cover letters (65)
Rett syndrome (17)
RNA editing (2)
RSV (49)
Schizophrenia (69)
Series A (64)
Series B (42)
Service/supplier (7)
Sickle cell disease (50)
Special edition (10)
Spinal muscular atrophy (73)
Sponsored (14)
Startups (1374)
State (1)
Stomach cancer (2)
Supply chain (34)
Tariffs (21)
The Weekly (15)
Vaccines (802)
Venture capital (24)
Weight loss (127)
Women's health (29)
Worklife (5)
Date
Today (1)
Last 7 days (323)
Last 30 days (1249)
Last 365 days (16081)
2025 (15585)
2024 (19050)
2023 (22599)
2022 (30957)
2021 (35415)
2020 (35793)
2019 (37697)
2018 (23586)
2017 (14344)
2016 (12484)
2015 (16118)
2014 (10938)
2013 (8093)
2012 (9060)
2011 (9951)
2010 (8572)
Location
Africa (306)
Alabama (36)
Alaska (3)
Arizona (106)
Arkansas (4)
Asia (20697)
Australia (2774)
California (5656)
Canada (1311)
China (447)
Colorado (268)
Connecticut (270)
Delaware (168)
Europe (41787)
Florida (1049)
Georgia (195)
Idaho (25)
Illinois (438)
India (23)
Indiana (290)
Iowa (15)
Japan (197)
Kansas (79)
Kentucky (9)
Louisiana (12)
Maine (52)
Maryland (688)
Massachusetts (3955)
Michigan (131)
Minnesota (278)
Mississippi (1)
Missouri (49)
Montana (9)
Nebraska (12)
Nevada (61)
New Hampshire (50)
New Jersey (1912)
New Mexico (3)
New York (1640)
North Carolina (635)
North Dakota (5)
Northern California (2735)
Ohio (124)
Oklahoma (4)
Oregon (7)
Pennsylvania (1247)
Puerto Rico (11)
Rhode Island (17)
South America (494)
South Carolina (36)
Southern California (2262)
Tennessee (83)
Texas (762)
United States (20579)
Utah (189)
Vermont (1)
Virginia (112)
Washington D.C. (34)
Washington State (511)
West Virginia (3)
Wisconsin (29)
Wyoming (1)
356,473 Results for "19".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
FDA Plans Black Box Warning for COVID-19 Vaccines: Report
The FDA intends to place a black box label—its most serious warning—on COVID-19 vaccines, according to reporting by
CNN
. It is unclear if the warning would apply to Moderna’s, Pfizer/BioNTech’s and Novavax’s shots, or to all age groups.
December 12, 2025
·
3 min read
·
Heather McKenzie
Vaccines
CDC Highlights Efficacy of COVID-19 Shots in Kids Amid FDA Probe of Alleged Deaths
The 2024–2025 formulations of COVID-19 vaccines had an effectiveness rate of 76% at preventing emergency or urgent care visits in children aged 9 months through four years, according to a new report.
December 12, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA To Provide Further Data on 10 Alleged Pediatric Deaths Linked to COVID-19 Vaccines By End of Month
Last week, Center for Biologics Evaluation and Research Director Vinay Prasad claimed in an internal memo—without providing evidence—that COVID-19 vaccines were responsible for the deaths of 10 children between 2021 and 2024.
December 4, 2025
·
2 min read
·
Tristan Manalac
CDC
CDC Adopts ACIP Recommendations on Chickenpox, COVID-19 Vaccines
A new group of CDC advisors voted last month to separate the chickenpox vaccine from the measles, mumps, rubella components of the MMRV shot due to concerns over febrile seizures, while recommending a more risk-based approach to COVID-19 immunizations that mirrors recent FDA approvals.
October 6, 2025
·
1 min read
·
Heather McKenzie
Vaccines
Prasad Signals Steeper Requirements for COVID-19 Vaccines
In a series of memos last week, Center for Biologics Evaluation and Research Director Vinay Prasad outlined the FDA’s thinking on the recent limited approvals for updated COVID-19 vaccines.
September 3, 2025
·
3 min read
·
Tristan Manalac
Vaccines
ACIP Meeting Delayed Indefinitely; COVID-19 Vaccines Continue To Show Benefit in New Study
The CDC’s Advisory Committee on Immunization Practices was scheduled to convene Oct. 22 to 23, but this meeting has been postponed, with no new date specified. The delay comes as the VA published new research showing that COVID-19 shots prevented hospitalizations and death.
October 9, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Kennedy Names New ACIP Members as Panel Quiets COVID-19 Vaccine Developers Ahead of Meeting
Like the first batch of appointees to the CDC’s vaccine advisory committee, several of the new panelists have documented histories of vaccine and COVID-19 skepticism.
September 16, 2025
·
2 min read
·
Tristan Manalac
Policy
Kennedy Promised Medical Freedom. New COVID-19 Vaccine Restrictions Provide the Opposite
During the COVID-19 pandemic, Health Secretary Robert F. Kennedy Jr.—along with FDA Commissioner Marty Makary and CBER Director Vinay Prasad—argued against vaccine mandates, partly because they limited medical choice. This week, the FDA under their leadership approved updated COVID-19 vaccines with restrictions that do the same.
August 29, 2025
·
5 min read
·
Heather McKenzie
Vaccines
FDA Clears Updated COVID-19 Shots From Pfizer, Moderna, Novavax—But With Restrictions
The American Academy of Pediatrics called the decision to limit children’s access to COVID-19 vaccines “deeply troubling.”
August 28, 2025
·
2 min read
·
Tristan Manalac
Vaccines
American Academy of Pediatrics Contradicts CDC, Recommends COVID-19 Shot for Kids
The CDC no longer recommends COVID-19 vaccines for healthy children and healthy pregnant women, a position that has been opposed by leading medical societies.
August 20, 2025
·
2 min read
·
Tristan Manalac
1 of 35,648
Next